624 Elexacaftor/tezacaftor/ivacaftor for treatment of cystic fibrosis: Experience in Argentina from October 2021 to March 2022.

Autor:	Martin, M. (AUTHOR), Mendez, A. (AUTHOR), Brown, M. (AUTHOR), Dziubecki, M. (AUTHOR), Damnotti, C. (AUTHOR), Basualdo, S. (AUTHOR), Nessi, M. (AUTHOR), Incardona, C. (AUTHOR)
Zdroj:	Journal of Cystic Fibrosis. 2022 Supplement 2, Vol. 21, pS344-S344. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect